News
Mathieu Roche discusses the role of identity in digital advertising performance, emphasizing transparent data collection and ...
Former club captain Barry Roche leaves Morecambe after 17 years at the Shrimps that spanned both playing and coaching roles.
The commercial and clinical use of Elevidys was discontinued after two fatal cases of acute liver failure.
Alainy Chiloh Roché is ready to tee up for a career in medicine or real estate development, but she will continue to improve ...
Roche and Prothena are advancing Prasinezumab to Phase 3 for Parkinson’s despite mixed Phase 2 results. Click here to read an ...
Roche's Venclexta failure does not affect the oncology pipeline, as HER2 franchise continues to drive revenue growth. Click ...
Roche and Prothena are forging ahead to late-stage studies for their investigational Parkinson’s disease antibody ...
With fewer than 200 trained dermatologists serving Malaysia's 33 million people[1]-just one specialist for every 165,000 ...
3d
Pharmaceutical Technology on MSNSarepta and Roche halt DMD gene therapy’s use after second deathShares in both companies were down following news of the second death, casting fresh safety concerns over Elevidys.
Roche entered into a Licensing, Development, and Commercialisation agreement with Prothena in December 2013 to develop and ...
Roche and AbbVie have once again come up short in their attempt to gain an additional indication for their blockbuster blood ...
Prothena Corporation plc (NASDAQ:PRTA) is an Ireland-based late-stage clinical biotechnology company that identifies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results